BIOMAT Database Logo BIOMAT Database Logo

Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. 1990

J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Department of Pharmacology, University of Colorado Health Sciences Center, Denver.

The purpose of this study was to test whether persistent changes consistent with behavioral sensitization occur in dopamine (DA) uptake, release or receptors following repeated cocaine administration. Our neurochemical experiments focused primarily on the striatum; however, quantitative autoradiography was used to measure D-1 and D-2 DA receptors in both cell body and terminal regions of the nigrostriatal and mesolimbic dopaminergic pathways. After receiving eight once-daily injections of cocaine (10 mg/kg, i.p.), rats remained behaviorally sensitized for 1 week. This repeated treatment with cocaine induced two changes consistent with increased dopaminergic transmission. Postsynaptic D-2 DA receptors were selectively increased in nucleus accumbens one day after termination of the repeated cocaine administration; however, these receptors returned to control levels one week after cocaine administration had been terminated. In contrast, amphetamine-stimulated [3H] DA release from striatal slices was increased in rats receiving repeated cocaine injections, but this increase was not apparent until 1 week after the drug administration had been terminated. While neither of these two changes is sufficient to explain cocaine-induced behavioral sensitization, both are consistent with increased dopaminergic responsiveness and may contribute to sensitization.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009627 Nomifensine An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266) Hoe-984,Linamiphen,Merital,Nomifensin,Nomifensine Maleate,Nomifensine Maleate (1:1),Hoe 984,Hoe984,Maleate, Nomifensine
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
January 1995, Molecular neurobiology,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration.
January 1993, Psychopharmacology,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration.
March 1994, Brain research. Molecular brain research,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Behavioural and neurochemical effects of repeated administration of cocaine in rats.
August 1978, Neuropharmacology,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors.
August 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration.
April 2000, Brain research,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
December 1989, The Journal of pharmacology and experimental therapeutics,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Dopamine D4 receptors linked to protein kinase G are required for changes in dopamine release followed by locomotor activity after repeated cocaine administration.
May 2015, Experimental brain research,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Neurochemical changes in cocaine withdrawal.
July 1996, Trends in pharmacological sciences,
J Peris, and S J Boyson, and W A Cass, and P Curella, and L P Dwoskin, and G Larson, and L H Lin, and R P Yasuda, and N R Zahniser
Dopamine uptake changes associated with cocaine self-administration.
April 2009, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!